Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu Si

Showing results (131-140 of 230) with videos related to

Pageof 23
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2013
A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanomaChuanliang Cui, Lili Mao, Zhihong Chi, et al.
Journal of Cancer Research and Clinical Oncology|November 30, 2017
Analysis of TSC1 mutation spectrum in mucosal melanomaMeng Ma, Jie Dai, Tianxiao Xu, et al.
Melanoma Research|August 8, 2018
Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeuticsJunya Yan, Xiaowen Wu, Jiayi Yu, et al.
Dermatology Practical & Conceptual|February 16, 2024
Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective StudyYu Du, Zhonghui Qi, Xianbin Liang, et al.
Urologic Oncology|June 30, 2022
Clinicopathological characteristics and prognosis of metastatic collecting duct carcinomaLi Zhou, Yiqiang Liu, Jiazhi Mo, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 24, 2019
miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapyHuan Tang, Meng Ma, Jie Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2017
<i>MAPK</i> Pathway and <i>TERT</i> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 CasesXue Bai, Yan Kong, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2016
GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosisXinan Sheng, Yan Kong, Yiqian Li, et al.
Translational Oncology|July 30, 2018
Safety and Efficacy of Apatinib Combined with Temozolomide in Advanced Melanoma Patients after Conventional Treatment FailureChuanLiang Cui, Li Zhou, Bin Lian, et al.
Frontiers in Pharmacology|December 3, 2021
Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical StudiesHui Tian, Xuan Wang, Bin Lian, et al.
Pageof 23

Showing results (131-140 of 230) with videos related to

Sort By:
Pageof 23
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2013
A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanomaChuanliang Cui, Lili Mao, Zhihong Chi, et al.
Journal of Cancer Research and Clinical Oncology|November 30, 2017
Analysis of TSC1 mutation spectrum in mucosal melanomaMeng Ma, Jie Dai, Tianxiao Xu, et al.
Melanoma Research|August 8, 2018
Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeuticsJunya Yan, Xiaowen Wu, Jiayi Yu, et al.
Dermatology Practical & Conceptual|February 16, 2024
Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective StudyYu Du, Zhonghui Qi, Xianbin Liang, et al.
Urologic Oncology|June 30, 2022
Clinicopathological characteristics and prognosis of metastatic collecting duct carcinomaLi Zhou, Yiqiang Liu, Jiazhi Mo, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 24, 2019
miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapyHuan Tang, Meng Ma, Jie Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2017
<i>MAPK</i> Pathway and <i>TERT</i> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 CasesXue Bai, Yan Kong, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2016
GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosisXinan Sheng, Yan Kong, Yiqian Li, et al.
Translational Oncology|July 30, 2018
Safety and Efficacy of Apatinib Combined with Temozolomide in Advanced Melanoma Patients after Conventional Treatment FailureChuanLiang Cui, Li Zhou, Bin Lian, et al.
Frontiers in Pharmacology|December 3, 2021
Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical StudiesHui Tian, Xuan Wang, Bin Lian, et al.
Pageof 23